Table 1.
Patient Characteristics before CART Procedures.
| Items | n=34, total 101 sessions | |
|---|---|---|
| Age, years | 68.7±10.6 (54-93) | |
| Male/Female | 27/7 | |
| Complications | ||
| HCC | 17 (50.0%) | |
| chronic renal failure | 8 (23.5%) | |
| hepatic encephalopathy | 3 (8.8%) | |
| esophageal varices | 7 (20.6%) | |
| Details of CART procedures the number of sessions | 3.0±2.9 (1-13) | |
| Body weight (kg) | 66.1±14.0 (47-104) | |
| Abdominal circumferences (cm) | 99.0±8.8 (76-120) | |
| Previous history of large volume paracentesis | 13 (12.9%) | |
| Concomitant drugs | ||
| anticancer drugs | 3 (3.0%) | |
| furosemide | 77 (76.2%) | |
| spironolactone | 49 (48.5%) | |
| thiazide | 4 (4.0%) | |
| tolvaptan | 54 (53.5%) | |
| Serum biochemistry | ||
| albumin (g/dL) | 2.4±0.5 (1.4-3.5) | |
| total bilirubin (mg/dL) | 2.1±2.9 (0.3-22.1) | |
| eGFR (mL/min/1.73?m2) | 51.9±21.7 (9.7-119.9) |
CART: cell-free and concentrated ascites reinfusion therapy, HCC: hepatocellular carcinoma, eGFR: estimate glomerular filtration rate